Stock Scorer

ARS Pharmaceuticals, Inc. (SPRY) · Insider trading

What ARS Pharmaceuticals's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.

Bought, 12 months
$0
0 insiders, 0 trades
Sold, 12 months
$1.95M
4 insiders, 15% under a plan
Net, 12 months
−$1.95M
bought less sold
Latest filing
2026-06-12
filings read to 2026-10-19

Bought and sold at the market, by month

Two years. Purchases above the line, sales below, in dollars.

2024-11: $17.71M sold 2024-12: $13.96M sold 2025-01: $555,000 sold 2025-01 2025-02: $615,500 sold 2025-03: $700,416 sold 2025-04: $615,025 sold 2025-05: $3.87M sold 2025-06: $13.90M sold 2025-07: $254,850 sold 2025-07 2025-08: $1.62M sold 2025-11: $1.67M sold 2026-01 2026-06: $283,550 sold 2026-07
Bought Sold Largest month: $17.71M

Who traded, two years

InsiderBoughtSold TradesLast tradeHolds after
Deerfield Management Company, L.P. (Series C)10% owner – $23.81M 10 2025-06-27 –
Chakma JustinChief Business Officer – $8.56M 13 2025-11-12 136,380
Lowenthal Richard EDirector, PRESIDENT AND CEO, 10% owner – $6.29M 11 2025-08-21 –
Tanimoto SarinaCHIEF MEDICAL OFFICER, 10% owner – $6.27M 12 2025-08-20 –
Shawver LauraDirector – $5.03M 9 2025-04-07 210,346
Saunders Brent LDirector – $1.71M 1 2025-05-20 0
Fitzpatrick Alexander AChief Legal Officer – $1.49M 2 2026-06-12 90,910
Karas EricChief Commercial Officer – $1.03M 6 2026-06-12 12,176
Scott Kathleen D.Chief Financial Officer – $892,500 2 2025-08-21 10,042
Dorsey BrianChief Operating Officer – $684,072 3 2025-11-13 10,789

Open-market purchases and sales

Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.

DateInsiderTradeShares PriceValueHolds afterFiling
2026-06-12 Fitzpatrick Alexander AChief Legal Officer Saleplan 3,355 10.00 $33,550 90,910 Form 4
2026-06-12 Karas EricChief Commercial Officer Saleplan 25,000 10.00 $250,000 12,176 Form 4
2025-11-13 Dorsey BrianChief Operating Officer Sale 21,828 8.71 $190,122 10,789 Form 4
2025-11-12 Chakma JustinChief Business Officer Sale 30,000 8.91 $267,300 136,380 Form 4
2025-11-12 Chakma JustinChief Business Officer Sale 136,380 8.86 $1.21M 0 Form 4
2025-08-21 Scott Kathleen D.Chief Financial Officer Saleplan 12,500 15.00 $187,500 10,042 Form 4
2025-08-21 Lowenthal Richard EDirector, PRESIDENT AND CEO, 10% owner Saleplanindirect 50,000 14.49 $724,500 1,196,494 Form 4
2025-08-20 Tanimoto SarinaCHIEF MEDICAL OFFICER, 10% owner Saleplanindirect 37,656 14.09 $530,573 1,247,447 Form 4
2025-08-19 Tanimoto SarinaCHIEF MEDICAL OFFICER, 10% owner Saleplanindirect 12,344 14.03 $173,186 1,285,103 Form 4
2025-07-01 Karas EricChief Commercial Officer Saleplan 15,000 16.99 $254,850 10,315 Form 4
2025-06-27 Deerfield Management Company, L.P. (Series C)10% ownerwith Flynn James E, Deerfield Private Design Fund III, L.P., Deerfield Mgmt III, L.P., Deerfield Private Design Fund IV, L.P., Deerfield Mgmt IV, L.P. Saleindirect 370,075 18.46 $6.83M 4,887,254 Form 4
2025-06-27 Deerfield Management Company, L.P. (Series C)10% ownerwith Flynn James E, Deerfield Private Design Fund III, L.P., Deerfield Mgmt III, L.P., Deerfield Private Design Fund IV, L.P., Deerfield Mgmt IV, L.P. Saleindirect 370,074 18.46 $6.83M 4,887,254 Form 4
2025-06-18 Karas EricChief Commercial Officer Saleplan 15,000 16.00 $240,000 7,696 Form 4
2025-05-20 Scott Kathleen D.Chief Financial Officer Sale 50,000 14.10 $705,000 7,424 Form 4
2025-05-20 Saunders Brent LDirector Sale 120,000 14.25 $1.71M 0 Form 4
2025-05-20 Fitzpatrick Alexander AChief Legal Officer Sale 102,969 14.10 $1.45M 89,613 Form 4
2025-04-07 Shawver LauraDirector Saleplan 50,002 12.30 $615,025 210,346 Form 4
2025-03-20 Karas EricChief Commercial Officer Saleplan 10,000 14.00 $140,000 7,696 Form 4
2025-03-06 Shawver LauraDirector Saleplan 49,600 11.21 $556,016 210,346 Form 4
2025-03-05 Shawver LauraDirector Saleplan 400 11.00 $4,400 210,346 Form 4
2025-02-03 Shawver LauraDirector Saleplan 50,000 12.31 $615,500 210,346 Form 4
2025-01-06 Shawver LauraDirector Saleplan 50,000 11.10 $555,000 210,346 Form 4
2024-12-17 Lowenthal Richard EDirector, PRESIDENT AND CEO, 10% owner Saleplanindirect 50,000 11.67 $583,500 1,297,447 Form 4
2024-12-17 Lowenthal Richard EDirector, PRESIDENT AND CEO, 10% owner Saleplanindirect 50,000 11.67 $583,500 1,098,499 Form 4
2024-12-17 Tanimoto SarinaCHIEF MEDICAL OFFICER, 10% owner Saleplanindirect 50,000 11.67 $583,500 1,297,447 Form 4
2024-12-17 Tanimoto SarinaCHIEF MEDICAL OFFICER, 10% owner Saleplanindirect 50,000 11.67 $583,500 1,098,499 Form 4
2024-12-13 Chakma JustinChief Business Officer Sale 27,272 12.06 $328,900 136,380 Form 4
2024-12-12 Dorsey BrianChief Operating Officer Saleplan 25,000 12.30 $307,500 6,024 Form 4
2024-12-12 Chakma JustinChief Business Officer Sale 117,333 12.27 $1.44M 136,380 Form 4
2024-12-11 Dorsey BrianChief Operating Officer Saleplan 15,000 12.43 $186,450 6,024 Form 4
2024-12-10 Chakma JustinChief Business Officer Sale 50,000 13.15 $657,500 136,380 Form 4
2024-12-10 Lowenthal Richard EDirector, PRESIDENT AND CEO, 10% owner Saleplanindirect 50,000 13.17 $658,500 1,246,494 Form 4
2024-12-10 Lowenthal Richard EDirector, PRESIDENT AND CEO, 10% owner Saleplanindirect 50,000 13.16 $658,000 1,148,499 Form 4
2024-12-10 Tanimoto SarinaCHIEF MEDICAL OFFICER, 10% owner Saleplanindirect 50,000 13.17 $658,500 1,246,494 Form 4
2024-12-10 Tanimoto SarinaCHIEF MEDICAL OFFICER, 10% owner Saleplanindirect 50,000 13.16 $658,000 1,148,499 Form 4
2024-12-06 Chakma JustinChief Business Officer Sale 50,000 14.23 $711,500 136,380 Form 4
2024-12-05 Chakma JustinChief Business Officer Sale 49,640 14.13 $701,413 136,380 Form 4
2024-12-04 Chakma JustinChief Business Officer Sale 45,000 13.95 $627,750 136,380 Form 4
2024-12-04 Karas EricChief Commercial Officer Saleplan 6,283 14.00 $87,962 5,693 Form 4
2024-12-04 Shawver LauraDirector Saleplan 14,772 13.75 $203,115 210,346 Form 4
29 more
2024-12-03 Shawver LauraDirector Saleplan 87,984 13.26 $1.17M 210,346 Form 4
2024-12-03 Chakma JustinChief Business Officer Sale 45,000 13.19 $593,550 136,380 Form 4
2024-12-02 Karas EricChief Commercial Officer Saleplan 3,717 14.11 $52,447 5,693 Form 4
2024-12-02 Shawver LauraDirector Saleplan 96,343 13.55 $1.31M 211,247 Form 4
2024-12-02 Shawver LauraDirector Saleplan 901 14.34 $12,920 210,346 Form 4
2024-12-02 Chakma JustinChief Business Officer Sale 45,000 13.67 $615,150 136,380 Form 4
2024-11-27 Chakma JustinChief Business Officer Sale 25,000 14.39 $359,750 136,380 Form 4
2024-11-26 Chakma JustinChief Business Officer Sale 42,186 14.05 $592,713 161,380 Form 4
2024-11-25 Chakma JustinChief Business Officer Sale 32,814 14.00 $459,396 203,566 Form 4
2024-11-19 Tanimoto SarinaCHIEF MEDICAL OFFICER, 10% owner Saleplanindirect 50,000 13.95 $697,500 1,347,447 Form 4
2024-11-19 Tanimoto SarinaCHIEF MEDICAL OFFICER, 10% owner Saleplanindirect 50,000 13.95 $697,500 1,198,499 Form 4
2024-11-19 Lowenthal Richard EDirector, PRESIDENT AND CEO, 10% owner Saleplanindirect 50,000 13.95 $697,500 1,347,447 Form 4
2024-11-19 Lowenthal Richard EDirector, PRESIDENT AND CEO, 10% owner Saleplanindirect 50,000 13.95 $697,500 1,198,499 Form 4
2024-11-12 Lowenthal Richard EDirector, PRESIDENT AND CEO, 10% owner Saleplanindirect 45,045 16.76 $754,954 1,301,449 Form 4
2024-11-12 Lowenthal Richard EDirector, PRESIDENT AND CEO, 10% owner Saleplanindirect 4,955 17.64 $87,406 1,296,494 Form 4
2024-11-12 Lowenthal Richard EDirector, PRESIDENT AND CEO, 10% owner Saleplanindirect 45,124 16.76 $756,278 1,253,375 Form 4
2024-11-12 Lowenthal Richard EDirector, PRESIDENT AND CEO, 10% owner Saleplanindirect 4,876 17.64 $86,013 1,248,499 Form 4
2024-11-12 Tanimoto SarinaCHIEF MEDICAL OFFICER, 10% owner Saleplanindirect 45,045 16.76 $754,954 1,301,449 Form 4
2024-11-12 Tanimoto SarinaCHIEF MEDICAL OFFICER, 10% owner Saleplanindirect 4,955 17.64 $87,406 1,296,494 Form 4
2024-11-12 Tanimoto SarinaCHIEF MEDICAL OFFICER, 10% owner Saleplanindirect 45,124 16.76 $756,278 1,253,375 Form 4
2024-11-12 Tanimoto SarinaCHIEF MEDICAL OFFICER, 10% owner Saleplanindirect 4,876 17.64 $86,013 1,248,499 Form 4
2024-11-12 Deerfield Management Company, L.P. (Series C)10% ownerwith Flynn James E, Deerfield Private Design Fund III, L.P., Deerfield Mgmt III, L.P., Deerfield Private Design Fund IV, L.P., Deerfield Mgmt IV, L.P. Saleindirect 7,853 17.16 $134,757 5,266,883 Form 4
2024-11-12 Deerfield Management Company, L.P. (Series C)10% ownerwith Flynn James E, Deerfield Private Design Fund III, L.P., Deerfield Mgmt III, L.P., Deerfield Private Design Fund IV, L.P., Deerfield Mgmt IV, L.P. Saleindirect 7,854 17.16 $134,775 5,266,881 Form 4
2024-11-12 Deerfield Management Company, L.P. (Series C)10% ownerwith Flynn James E, Deerfield Private Design Fund III, L.P., Deerfield Mgmt III, L.P., Deerfield Private Design Fund IV, L.P., Deerfield Mgmt IV, L.P. Saleindirect 9,554 17.77 $169,775 5,257,329 Form 4
2024-11-12 Deerfield Management Company, L.P. (Series C)10% ownerwith Flynn James E, Deerfield Private Design Fund III, L.P., Deerfield Mgmt III, L.P., Deerfield Private Design Fund IV, L.P., Deerfield Mgmt IV, L.P. Saleindirect 9,553 17.77 $169,757 5,257,328 Form 4
2024-11-11 Deerfield Management Company, L.P. (Series C)10% ownerwith Flynn James E, Deerfield Private Design Fund III, L.P., Deerfield Mgmt III, L.P., Deerfield Private Design Fund IV, L.P., Deerfield Mgmt IV, L.P. Saleindirect 40,596 17.45 $708,400 5,498,368 Form 4
2024-11-11 Deerfield Management Company, L.P. (Series C)10% ownerwith Flynn James E, Deerfield Private Design Fund III, L.P., Deerfield Mgmt III, L.P., Deerfield Private Design Fund IV, L.P., Deerfield Mgmt IV, L.P. Saleindirect 40,596 17.45 $708,400 5,498,367 Form 4
2024-11-11 Deerfield Management Company, L.P. (Series C)10% ownerwith Flynn James E, Deerfield Private Design Fund III, L.P., Deerfield Mgmt III, L.P., Deerfield Private Design Fund IV, L.P., Deerfield Mgmt IV, L.P. Saleindirect 223,632 18.15 $4.06M 5,274,736 Form 4
2024-11-11 Deerfield Management Company, L.P. (Series C)10% ownerwith Flynn James E, Deerfield Private Design Fund III, L.P., Deerfield Mgmt III, L.P., Deerfield Private Design Fund IV, L.P., Deerfield Mgmt IV, L.P. Saleindirect 223,632 18.15 $4.06M 5,274,735 Form 4

Grants, exercises and other transactions

Pay, tax and paperwork rather than a choice to trade at the market price. Two years.

41 × option exercise2 × gift
Show them
DateInsiderWhatShares PriceHolds afterFiling
2026-06-12 Karas EricChief Commercial Officer Option exercise M +25,000 1.50 37,176 Form 4
2025-11-13 Dorsey BrianChief Operating Officer Option exercise M +21,828 0.64 32,617 Form 4
2025-11-12 Shah PratikDirector Gift G −250,000 – 4,574,554 Form 4
2025-11-12 Shah PratikDirector Gift G −100,000 – 4,474,554 Form 4
2025-11-12 Chakma JustinChief Business Officer Option exercise M +30,000 0.84 166,380 Form 4
2025-08-21 Scott Kathleen D.Chief Financial Officer Option exercise M +12,500 1.50 22,542 Form 4
2025-07-01 Karas EricChief Commercial Officer Option exercise M +15,000 1.50 25,315 Form 4
2025-06-18 Karas EricChief Commercial Officer Option exercise M +15,000 1.50 22,696 Form 4
2025-05-20 Scott Kathleen D.Chief Financial Officer Option exercise M +50,000 1.50 57,424 Form 4
2025-05-20 Saunders Brent LDirector Option exercise M +120,000 1.01 120,000 Form 4
2025-05-20 Fitzpatrick Alexander AChief Legal Officer Option exercise M +100,000 5.58 192,582 Form 4
2025-04-07 Shawver LauraDirector Option exercise M +22,509 4.85 232,855 Form 4
2025-04-07 Shawver LauraDirector Option exercise M +27,493 4.85 260,348 Form 4
2025-03-20 Karas EricChief Commercial Officer Option exercise M +10,000 1.50 17,696 Form 4
2025-03-06 Shawver LauraDirector Option exercise M +49,600 4.85 259,946 Form 4
2025-03-05 Shawver LauraDirector Option exercise M +400 4.85 210,746 Form 4
2025-02-03 Shawver LauraDirector Option exercise M +9,064 3.15 219,410 Form 4
2025-02-03 Shawver LauraDirector Option exercise M +40,936 4.85 260,346 Form 4
2025-01-06 Shawver LauraDirector Option exercise M +50,000 3.15 260,346 Form 4
2024-12-13 Chakma JustinChief Business Officer Option exercise M +27,272 1.44 163,652 Form 4
2024-12-12 Dorsey BrianChief Operating Officer Option exercise M +25,000 0.64 31,024 Form 4
2024-12-12 Chakma JustinChief Business Officer Option exercise M +117,333 0.84 253,713 Form 4
2024-12-11 Dorsey BrianChief Operating Officer Option exercise M +15,000 0.64 21,024 Form 4
2024-12-10 Chakma JustinChief Business Officer Option exercise M +50,000 0.84 186,380 Form 4
2024-12-06 Lowenthal Richard EDirector, PRESIDENT AND CEO, 10% owner Option exercise M +11,876 8.42 4,327,189 Form 4
2024-12-06 Lowenthal Richard EDirector, PRESIDENT AND CEO, 10% owner Option exercise M +13,789 1.44 3,421,636 Form 4
2024-12-06 Lowenthal Richard EDirector, PRESIDENT AND CEO, 10% owner Option exercise M +11,876 8.42 3,433,512 Form 4
2024-12-06 Tanimoto SarinaCHIEF MEDICAL OFFICER, 10% owner Option exercise M +13,789 1.44 3,421,636 Form 4
2024-12-06 Tanimoto SarinaCHIEF MEDICAL OFFICER, 10% owner Option exercise M +11,876 8.42 3,433,512 Form 4
2024-12-06 Tanimoto SarinaCHIEF MEDICAL OFFICER, 10% owner Option exercise M +11,876 8.42 4,327,189 Form 4
2024-12-06 Chakma JustinChief Business Officer Option exercise M +50,000 0.84 186,380 Form 4
2024-12-05 Chakma JustinChief Business Officer Option exercise M +49,640 0.84 186,020 Form 4
2024-12-04 Chakma JustinChief Business Officer Option exercise M +45,000 0.84 181,380 Form 4
2024-12-04 Karas EricChief Commercial Officer Option exercise M +6,283 1.50 11,976 Form 4
2024-12-04 Shawver LauraDirector Option exercise M +14,772 3.15 225,118 Form 4
2024-12-03 Shawver LauraDirector Option exercise M +25,606 1.27 235,952 Form 4
2024-12-03 Shawver LauraDirector Option exercise M +62,378 3.15 298,330 Form 4
2024-12-03 Chakma JustinChief Business Officer Option exercise M +3,260 0.84 139,640 Form 4
2024-12-03 Chakma JustinChief Business Officer Option exercise M +41,740 0.84 181,380 Form 4
2024-12-02 Karas EricChief Commercial Officer Option exercise M +3,717 1.50 9,410 Form 4
2024-12-02 Shawver LauraDirector Option exercise M +67,616 1.27 277,962 Form 4
2024-12-02 Shawver LauraDirector Option exercise M +29,628 1.27 307,590 Form 4
2024-12-02 Chakma JustinChief Business Officer Option exercise M +45,000 0.84 181,380 Form 4

How to read it

Buy, sale
Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
Plan
A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
Holds after
The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
Value
Shares times the price the form reports, which is often an average over several fills on the day.

Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.

ARS Pharmaceuticals's scores and multiples ›